Director/Sr Director, Biostatistics

Description
Director / Senior Director, Biostatistics
About Company:
Clinical-stage biopharmaceutical company pioneering mRNA-engineered CAR-T cell therapies for severe autoimmune diseases. Our lead asset, Descartes-08, an anti-BCMA autologous mRNA CAR-T therapy, has received RMAT designation for generalized myasthenia gravis (gMG) and is currently being evaluated across a portfolio of clinical programs:
• AURORA — Phase 3 randomized, double-blind, placebo-controlled trial in gMG
• TRITON — Phase 2 randomized controlled trial in dermatomyositis and antisynthetase syndrome
• HELIOS — Phase 1/2 trial in juvenile dermatomyositis
• Planned in vivo CAR-T program in the United States — early-stage strategic development
We are a data-driven organization committed to rigorous clinical science, regulatory excellence, and rapid translation of breakthrough therapies to patients with limited treatment options.
Position Summary:
Seeking an experienced and strategically...